Removal of Anti-Angiogenic Proteins in Preeclampsia Before Delivery (RAAPID-II)

This study has been completed.
Kaneka Pharma America LLC
Information provided by (Responsible Party):
Ravi Thadhani, Massachusetts General Hospital Identifier:
First received: July 26, 2011
Last updated: September 25, 2015
Last verified: September 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2015
  Primary Completion Date: September 2015 (Final data collection date for primary outcome measure)
Thadhani R, Hagmann H, Schaarschmidt W, Roth B, Cingoez T, Karumanchi SA, Wenger J, Lucchesi KJ, Tamez T, Lindner T, Fridman A, Thome U, Kribs A, Danner M, Hamacher S, Mallmann P, Stepan H and Benzing T. Removal of Soluble Fms-Like Tyrosine Kinase-1 by Dextran Sulfate Apheresis in Preeclampsia. JASN ASN.2015020157; published ahead of print September 24, 2015, doi:10.1681/ASN.2015020157